UK Government – Page 137 – The NEN

Which? warns consumer concerns risk being overlooked in plans to restart international travel

Plans to restart foreign travel for millions of people could be doomed to fail if the government does not effectively consult consumers and reassure them that trips abroad will be safe, affordable and their refund rights will be upheld, according to Which?.

The UK government’s Global Travel Taskforce (GTT) is due to outline how it will restart international travel, currently set to reopen no earlier than 17 May, when it publishes its report in early April.

However, Which? is concerned that limited opportunities for travellers to engage with the GTT could mean that their concerns won’t be addressed ahead of international travel reopening.

The GTT page on the government’s website says it is consulting with a range of groups, including the transport industry, international partners, the tourism sector, the private testing sector, and academia and policy institutes.

Engagement with consumers seems to be largely limited to an email address that travellers can send their concerns about travel reopening to, and even this is not listed clearly on the GTT web page for passengers to find.

Today, Which? is publishing its list of consumer priorities for travel, which the GTT must take on board if its plans to restart international travel are to be successful. They focus on vital measures to build passenger confidence around the safety of travel, accessibility and affordability of Covid tests and vaccine passports and assurances that holidaymakers will not be left out of pocket by coronavirus travel disruption.

Which? is also urging people to share their experiences with the Taskforce of how the pandemic has affected their travel plans over the past year and their concerns ahead of travel reopening via email or social media in the two weeks left before the GTT is due to report.

For more than a year now, the consumer champion has been hearing from people who have been let down by their travel provider after the pandemic grounded most international travel, which saw confidence in the industry plunge to a record low.

According to the Competition and Markets Authority, cancellation and refund complaints have accounted for the overwhelming majority of complaints to the regulator since April 2020, with around 47,000 cancellation complaints about holiday companies since March 2020, and more than 10,000 cancellation complaints about airlines.

Though many holiday companies and airlines have since improved their performance, Which? is warning that travellers risk facing another summer of chaos and cancelled holidays if the government does not provide assurances around safety, testing costs, health travel certificates, and how bookings will be protected from changing travel restrictions and associated costs, such as Foreign, Commonwealth and Development Office (FCDO) warnings against travel or the potential of costly hotel quarantine for arrivals from popular destinations.

With the risk of variants of the virus present in other countries being transmitted and brought back to the UK, it is essential that the government ensures that effective measures are put in place to ensure international travel is safe, particularly in airports.

Last summer, Which? reported that passengers endured queues in Stansted Airport with no social distancing, raising concerns around how airports will cope this summer if mass air travel is allowed to resume.

Given the limited data available on the ability of vaccines to reduce transmission, Which? is asking the GTT to ensure that clear guidance is in place for airports to facilitate social distancing between passengers, particularly in instances where passengers from ‘red list’ countries are travelling.

Which? is also concerned that travellers could face astronomical costs for testing, which is likely to be required for entry into most destinations this summer. Most countries now require a negative test before departure and a follow up on arrival, and passengers also need a negative test to return to the UK, and further tests on day two and eight of quarantine.

With PCR private tests costing around £120 each, the potential of up to five tests could mean travellers face paying hundreds more on top of the cost of their trip, potentially pricing people out of travelling.

Which? has also found that testing costs in the UK are considerably higher than in other countries. When it looked at the total cost of all the tests passengers would need for travel to a number of popular destinations across Europe, it found that the cost of tests were much lower on average compared to the UK. In Italy, for example, the average cost is €86 (£74) per test.

Additionally, Which? understands there will be a need for travel health certification, such as vaccine passports, but believes people need reassurance over how these will operate internationally, how their privacy will be maintained and their data protected, and what provisions will be made for those who cannot or do not want to rely on digital certifications. It is also essential that if certification is to be mandatory for travel, that it is provided free of charge.

The consumer champion is also urging the Taskforce to consider how travellers’ money will be protected if they cannot legally or reasonably travel to their destination because of coronavirus restrictions.

Despite many airlines offering reassurances that passengers can benefit from flexible booking policies this summer, Which? continues to hear from people who are still out of pocket for holidays that were disrupted last year.

Suzanna Mahoney, from Leeds, booked a holiday to Lanzarote with Loveholidays in January 2020. She was due to travel in August 2020, but when the time came, Loveholidays informed her that the FCDO advice for travel to Lanzarote had changed and asked if she still intended to travel.

Not wanting to travel against government advice, she chose the option of cancelling her holiday and was refunded the cost of her accommodation. She has not received a refund for the cost of her flights though, as they departed as scheduled, and has been left £1,600 out of pocket as a result.

Which? is engaging with the GTT and has shared its calls on the Taskforce to deliver for consumers.

It is asking the Taskforce to ensure that travellers will be given clear information about changing travel rules by the government and travel providers, that international travel will be safe, that they won’t face unreasonable additional costs and that the financial risk to consumers is minimised, that they will be able to get their money back if their holiday can’t go ahead, and that any travel health certification will be private and secure.

Until the Taskforce has published its report, Which? is advising people not to book any international travel or holidays, and wait until details of the GTT’s roadmap have been revealed before making any plans.

Rory Boland, Editor of Which? Travel, said: “Many of us are looking forward to the opportunity to step on a plane and travel to family and friends or take a holiday again in the near future, but the past year has taught us that there are a number of risks involved with international travel that need to be removed or reduced before we will be comfortable doing so.

“Confidence in overseas travel has plummeted as a result of the pandemic, and government interventions for both the industry and passengers who have been let down by their operator or airline have been woefully insufficient.

“The Taskforce has a real opportunity to give passengers the confidence to travel again, but it must take their concerns into consideration, or else it risks another disastrous summer for passengers and industry alike.”

A spokesperson for Loveholidays said: “As we have done with all our customers who had holidays booked to a destination where the FCDO subsequently advised against traveling, we asked Ms Mahoney whether she wished to go ahead with her trip and gave her the option to cancel or amend her booking.

“She opted to cancel and we waived our cancellation fee and provided her with a full cash refund for the part of the holiday that we are able to do so – her hotel booking. As a change of FCDO advice does not of itself trigger cancellation and full refund rights under the PTRs, any flight refund is dependent on Ryanair agreeing to do so, which to date they have not. This was made clear when Ms Mahoney chose to cancel.

“Unfortunately, some airlines including Ryanair, chose to continue to operate flights despite a change in FCDO guidance for that destination. In accordance with Ryanair’s terms and conditions, they refuse to provide customers with a cash refund if a flight is still going ahead even if a customer quite understandably chooses to not to travel in light of the latest FCDO advice.

“Ryanair holds the flight sums. If we had received a flight refund from Ryanair, we would have forwarded this to Ms Mahoney within five working days of receipt, as we have done with many other customers who cancelled in the same circumstances.”

Edinburgh Festivals welcome £1 million UK Government support

Edinburgh Festivals – the biggest combined festivals in the country – will benefit from £1 million from the UK Government this year

Half a million pounds will fund a new digital platform to promote UK talent and content to both international and domestic producers

£500,000 will be made available for Festival organisers to increase their digital capabilities

The UK Government will fund two new projects to expand the digital potential of the Edinburgh Festivals with £1 million investment, Culture Secretary Oliver Dowden has announced.

The Edinburgh Festivals are the biggest combined festivals in the UK, attracting audiences of nearly 5 million every year, generating £313 million for Scotland’s economy alone, and providing unparalleled opportunities for artists across the country.

Last year many shows at the Edinburgh Festivals had to move online due to the coronavirus pandemic.

The challenge of moving to a combination of physical and online events, and the increased demand for British virtual cultural content around the globe, revealed the need to expand the Edinburgh Festivals’ digital capabilities as part of the cultural sector’s post-Covid recovery.

The UK Government is providing £1 million in funding for digital improvements that will enable more ways for people to virtually access the events across the country, increase opportunities for UK artists and ensure Edinburgh’s landmark events will continue to be major contributors to the UK’s economy and cultural landscape.

The 11 festivals in the Festivals Edinburgh event portfolio will be able to apply for a share of a new £500,000 fund which will support innovative virtual solutions to the challenges of commissioning, producing and promoting festival programmes in an increasingly digitised cultural sector.

The funding will help encourage collaboration between events and develop hybrid events with live and digital elements.

Another £500,000 will be provided to create a new digital platform that will help national and international buyers and producers search for talent and content from the festivals’ hugely varied programmes, which showcase thousands of artists and performers every year, and promote the work of British artists and performers around the world.

The funds will be available to Festivals Edinburgh this financial year. Events with live audiences at limited capacities in Scotland will return no earlier than 17 May, and further details about the planning for this year’s Edinburgh Festivals will be released in due course.

This funding builds on £100,000 previously awarded to the Edinburgh Fringe Festival in 2018 to better connect UK artists with international producers. As part of ongoing support for culture in Edinburgh, the UK Government provided £10 million for the Dunard Centre, through the Edinburgh and South East Scotland City Region Deal.

It will be the city’s first dedicated new space for music and the performing arts in 100 years. Scotland also received £97 million from the UK Government’s Culture Recovery Fund to provide support for the nation’s arts and cultural sectors.

Lothian MSP candidate for Edinburgh Southern, Miles Briggs, said: “This funding from the UK government is a very welcome investment into the arts and supporting the Edinburgh festival.

“It has been an exceptionally challenging year for artists and performers, many of whom have needed to adapt to virtual audiences.

“This investment will pave the way for hybrid Edinburgh Festival performances, which will allow people around the globe to see the creativity and talent on show in Edinburgh.”

Oliver Dowden, Culture Secretary, said: “Edinburgh’s Festivals have long been a springboard for the very best of British talent and a vital part of culture in Scotland and the UK.

“The UK Government’s investment will promote it to a worldwide audience online, helping the UK’s biggest combined festival build back better from the pandemic.”

“This is on top of £97 million we provided last year to the Scottish Government to support Scotland’s arts organisations through the pandemic. Like everyone else, I look forward to our fantastic arts and culture coming back better than ever before, as soon as it is safe to do so.”

Iain Stewart, UK Government Minister for Scotland, said: “Edinburgh is world-famous for its festivals, bringing wider benefits to Scotland’s economy, tourism and arts sectors.

“We know the last 12 months have been difficult for the culture sector. This £1 million funding boost will support organisations to improve their digital capabilities and engage with audiences here in Scotland and further afield.”

Sorcha Carey, Chair, Festivals Edinburgh, said: “While live events in Edinburgh will remain the backbone of our world-class festivals, it’s crucial that we enhance our digital operations and so we’re delighted with this incredible support from the UK Government which will help reposition our work, and the work of creatives, across the digital world.”

Sir James Macmillan, Composer, said: “I’m delighted and encouraged to see this significant and notable support being given to the Edinburgh Festivals at this crucial point.

“The arts have been seriously affected by the pandemic and it is wonderful that the UK Government is showing its tangible commitment to culture in Scotland by investing in one of Scotland’s and Britain’s most important arts organisations.”

Lockdown one year on: Prime Minister Boris Johnson reflects

PM statement at coronavirus press conference: 23 March

Good afternoon everybody, thank you for joining us.

When I asked you to go into lockdown exactly a year ago it seemed incredible that in the 21st Century this was the only way to fight a new respiratory disease: to stay at home, to avoid human contact, to shun so many of the patterns of behaviour that are most natural and obvious to all of us.

But we did it together, to protect the NHS, to save lives.

And for the entire British people it has been an epic of endurance and privation, of children’s birthday parties cancelled, of weddings postponed, of family gatherings of all kinds simply deleted from the diary.

And worst of all in that time we’ve suffered so many losses and for so many people our grief has been made more acute because we have not been able to see our loved ones in their final days, to hold their hands or even to mourn them together.

And at the right moment, we will come together as a country to build a fitting and a permanent memorial to the loved ones we have lost and to commemorate this whole period.

For month after month our collective fight against Coronavirus was like fighting in the dark against a callous and invisible enemy, until science helped us to turn the lights on and to gain the upper hand.

And I want to renew my thanks to everyone responsible for the astounding vaccine roll-out which has enabled us to protect more than 28 million people across the whole of the United Kingdom with a first jab and administer more than 30 million doses in total.

And I want to thank everybody for their courage, your courage, discipline and patience.

When people come to describe this epidemic to future generations, we’ll tell the story of the heroes of the NHS and social care of pharmacists, teachers, armed service personnel, shop workers, transport workers, the police and so many others.

But in the end this was unlike any other struggle in my lifetime, in that our entire population has been engaged, and it’s thanks to all of you therefore that we can continue on our roadmap to freedom.

We will meet our targets, offering a first dose to everyone over 50 by the middle of next month, as well as those under 50 who are clinically vulnerable, and offering a first dose of the vaccine to every adult by the end of July.

And cautiously but irreversibly, step by step, jab by jab, this country is on the path to reclaiming our freedoms.

UK Government announces more staff for Edinburgh trade hub

New trade hubs will channel the economic benefits of international trade directly into Scotland, Wales, Northern Ireland and the North of England.

Four major new trade and investment hubs will be established in Scotland, Wales, Northern Ireland and the North-East of England to boost trade and investment and level-up the country, the International Trade Secretary will announce today (23 March 2021).

The trade hubs in Edinburgh, Cardiff, Belfast and a new second major DIT site in Darlington, will be established as part of a new strategy to boost exports and bring the benefits of the government’s global trade policy to the whole of the UK, including benefits from future free trade agreements with the US, Australia, New Zealand and CPTPP.

They will mean exporters have a direct feed into UK trade policy, and can better take advantage of opportunities in fast-growing markets like the Indo-Pacific region.

The trade hubs will also create a critical link between the regions and the resources of the Office For Investment – a joint initiative with the Prime Minister’s Office – to channel investment money into every UK nation and region.

The trade hubs will be home to teams of export and investment specialists, who can provide businesses with expert support and advice to help them:

maximise their export potential and boost their trade in new markets overseas
better access major trade markets like India, the US and Japan
feed directly into DIT’s free trade agreements programme

The launch of the trade hubs marks the start of a major export drive, which will see DIT focussed on promoting British exports from all parts of the UK, to help level up the country, build back better, and support a resilient economy as outlined in the government’s Integrated Review.

Earlier this month government-led research showed exports support 6.5m jobs across the UK, 74% of which are outside London. The research estimates jobs directly and indirectly supported by exports pay around 7% higher than the national median, with Office for National Statistics estimating that goods exporting businesses are also 21% more productive.

The new trade hubs will also support the launch of high-profile export campaigns due to launch later this year, that will seek to maximise export potential and boost UK enterprise in global markets, following the recent launch of the food and drink export campaign.

Last year, goods exports from the North of England, Scotland, Wales, and Northern Ireland were £98.4bn.

International Trade Secretary Liz Truss said: “I’m determined to use UK trade policy to benefit every part of the UK. These Trade and Investment Hubs will help this country to an export and jobs-led recovery.

“They will mean we can channel investment into all corners of the country, and that exporters – whether they’re selling Scotch beef, Welsh Lamb or cars made in the North of England – have access to the expertise they need to sell into the fastest growing markets.”

550 staff are expected to be present in the hubs by 2025, with an ambition to increase this to 750 staff by 2030.

The existing DIT Hub in Edinburgh, announced in September last year, will see a ‘significant increase in headcount’ (i.e. mair staff! – Ed.) – following its relaunch today.

Half of all adults in UK receive first dose of COVID-19 vaccine

Almost 95% of people aged 60 and over have been vaccinated

Health Secretary hails strength of the Union as UK passes major vaccine milestone
Matt Hancock calls on everyone to accept the jab when it’s offered

Half of all adults in the UK have received their first dose of the (coronavirus) COVID-19 vaccine, the latest figures show.

The UK health services vaccinated a total of 26.8 million people between 8 December and 19 March with first doses, while 2.1 million people have had their second dose so far.

The rollout is continuing at pace and the UK is on track to achieve the Prime Minister’s target of offering the vaccine to all over-50s by 15 April, as well as all adults by the end of July.

Health Secretary Matt Hancock said: “Vaccinating over half of all adults is a phenomenal achievement and is testament to the mammoth efforts of the NHS, GPs, volunteers, local authorities and civil servants in every corner of the UK.

“It shows the strength of the Union and what can be achieved when we work together as one United Kingdom to protect those most at risk. But the job is not done yet.

“During April, we will continue to vaccinate those most at risk and around 12 million people will receive their second doses as well. It is absolutely crucial people come forward as soon as they are eligible. When you get the call, get the jab, because the more people who are vaccinated the safer we will all be.”

The pace of the rollout means even more people will soon develop strong protection from serious illness from COVID-19 infection, saving lives and significantly reducing pressure on the NHS, which supports the Prime Minister’s roadmap to ease lockdown restrictions.

Around 4% of the adult population have had their second doses so far and there will be a strong drive over the coming weeks to vaccinate people with the second jabs within 12 weeks, as well as continuing to vaccinate those in the priority groups with first doses.

The UK government’s Vaccine Taskforce secured early access to 457 million doses of the most promising vaccines on behalf of the whole of the UK, Crown Dependencies and Overseas Territories. This allowed a co-ordinated and rapid deployment of vaccines to those most at risk.

Vaccines Minister Nadhim Zahawi (above) said: “I would like to thank everybody involved in this incredible vaccination programme across the whole of the UK for their tireless dedication to protecting the most vulnerable and saving lives.

“This is a momentous occasion and while the vaccines are the best way out of this terrible pandemic, the battle is not yet over.

“We continue to do everything we can to expand the vaccination programme even further and encourage people of all backgrounds and religions to get their jabs when eligible.”

All vaccines being used in the UK have undergone robust clinical trials and have met the Medicines and Healthcare products Regulatory Agency’s (MHRA) strict standards of safety, effectiveness and quality.

The Moderna vaccine has also been approved by the MHRA and will be deployed from the spring. Rolling reviews are also underway by the MHRA to assess the Janssen and Novavax vaccines.

Data from Public Health England’s real-world study shows that both the Pfizer and Oxford-AstraZeneca vaccines are highly effective in reducing COVID-19 among older people aged 70 years and over. We are already seeing a significant impact of the vaccination programme on reducing hospitalisations and deaths, and it is vital people come forward for their vaccine when invited.

The vaccines are available for free from thousands of vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England, which includes mosques, Westminster Abbey and football stadiums.

Dr Nikki Kanani, NHS England’s primary care director and a GP, said: “Thanks to careful planning and the huge efforts of NHS vaccinators, volunteers and everyone working behind the scenes, the roll-out of the NHS vaccination programme – the biggest in health service history – continues to be a huge success.

“Their efforts meant the NHS had vaccinated half of all adults in England by Thursday, and as a GP and a vaccinator, it is source of great pride that we have now reached that major milestone across the whole of the UK.

“I would encourage anyone who is invited to come forward and book their vaccine. It is safe, quick and effective, and by having your vaccine you will join nearly 23 million people across England who’ve now been protected.”

Royal Pharmaceutical Society President Sandra Gidley said: “Vaccinating half of the UK population in such a short period of time is a huge achievement and I’m immensely proud of the role pharmacy teams have played.

“Pharmacists have been at the forefront of COVID-19 vaccinations, developing new treatments, ensuring a safe supply chain, and supporting vaccination clinics across the health service.

“I want to thank pharmacists working up and down the country in every setting, from large hospitals to those providing vaccinations in village halls, for their amazing efforts and for rising to the challenge during a time of national crisis.

“As we look to build on this success, pharmacists will continue to play a vital role in encouraging uptake of vaccines, particularly in communities where there are significant health challenges.

Professor Martin Marshall, Chair of the Royal College of GPs, said: “The hard work of GPs and our teams, along with colleagues across the NHS, to deliver the COVID-19 vaccination programme has been outstanding and ensured that vulnerable patients across the UK are protected from this terrible virus.

“It is excellent news that half the UK adult population – 26.8m people – have now received the first dose of the vaccine, with around 75% of these vaccinations taking place in primary care.

“This is an incredible milestone and the efforts of GPs and our teams have been pivotal to achieving it in such a short space of time, and despite the complexities and challenges of delivering a new vaccination programme on such a large scale.

“However, the hard work is far from over, and as long as there is supply, GPs and our teams will continue to vaccinate. Getting vaccinated is the best protection we have against this virus, and our best hope of getting back to a more normal life.

“We encourage patients to come forward for a vaccination when invited to do so.”

Background information

There are a total of 52.7 million adults in the UK based on ONS data.
PHE’s real-world data shows the efficacy of COVID-19 vaccines.
Through the government’s Vaccines Taskforce, the UK has secured early access to 457 million doses of 8 of the most promising vaccine candidates, including:
- BioNTech/Pfizer for 40 million doses
- Oxford/AstraZeneca for 100 million doses
- Moderna for 17 million doses
- GlaxoSmithKline and Sanofi Pasteur for 60 million doses
- Novavax for 60 million doses
- Janssen for 30 million doses
- Valneva for 100 million doses
- CureVac for 50 million doses
To date, the government has invested over £300 million into manufacturing a successful vaccine to enable a rapid roll out.

The UK government is committed to supporting equitable access to vaccines worldwide. The UK is the largest donor to the COVAX facility, the global mechanism to help developing countries access a coronavirus vaccine, and has committed £548 million in UK aid to help distribute 1.3 billion doses of coronavirus vaccines to 92 developing countries this year.

Borderlands Deal will build on success of Edinburgh Napier-led Mountain Bike Centre of Scotland

The Borderlands Inclusive Growth Deal was signed yesterday, confirming millions of pounds of investment into the Scottish Borders.

Ministers of the UK and Scottish Governments and representatives of the five councils of the Borderlands Partnership signed the deal, which aims to drive inclusive growth and deliver significant and lasting benefits for individuals, businesses and communities, including the creation of up to 5,500 jobs.

For the Scottish Borders, investment will include:

· £19m for an ambitious project to create the world’s first Mountain Bike Innovation Centre, integrated adventure Bike Park and Trail Lab in Innerleithen (further details below)

· £11m Destination Tweed tourism project based around the River Tweed

· Funding to further develop the 7Stanes mountain biking network across the Borders and Dumfries and Galloway

· A share of £20m for town and community improvement projects through a Place Programme in the south of Scotland

· Funding for improved business infrastructure in Hawick and Coldstream

· Funds to support rural innovation and skills

· Projects to tackle gaps in digital and mobile infrastructure

· £10m to deliver the feasibility activity around extending the Borders Railway from Tweedbank to Carlisle

· Funding to support the generation of low carbon energy

· Pilot projects covering woodland, upland and agricultural areas to trial new approaches to valuing and protecting our natural capital to capture the benefits of our environment in a sustainable way

Councillor Mark Rowley, Scottish Borders Council’s Executive Member for Economic Regeneration and Finance, said: “The Borderlands Inclusive Growth Deal has been worked on by the various partners for a number of years and this level of investment and joined up partnership working has never been more important than it is today, as we look towards our recovery from the COVID-19 pandemic.

“This deal can transform the Scottish Borders, allowing multiple, large scale projects to be taken forward by the Council and a wide range of partners, delivering new jobs and sustainable growth which will help support the region for decades to come.

“Significant investment into our towns and communities, our tourism infrastructure and our environment means that this deal will see the benefits shared right across the whole of the Scottish Borders.”

Innerleithen Mountain Bike Innovation Centre/Tweed Valley Bike Park and Trail Lab

A key element of the Borderlands Growth Deal for the Scottish Borders is the development of a new mountain bike innovation centre in Innerleithen that will support Scottish, UK and international businesses to develop innovative products and services within mountain biking and across the cycling sector.

In addition, a Tweed Valley Bike Park and Trail Lab will be created in what is thought to be a global first in terms of combining tourism and innovation. An adventure bike park will deliver infrastructure to attract and sustainably manage visitors to the Scottish Borders.

Borderlands Growth Deal will invest £19million in the project, which is predicted to contribute £141m in Gross Value Added (GVA) and over 400 new jobs in the South of Scotland.

The project partnership includes South of Scotland Enterprise as project sponsors Scottish Borders Council, Edinburgh Napier University and Scottish Cycling, through Developing Mountain Biking in Scotland (DMBinS).

Ed Shoote of DMBinS, the Senior Project Manager of the Mountain Bike Project, said: “It is fantastic news that the Borderlands Inclusive Growth Deal, including the Mountain Bike Project, is pushing ahead.

“The vision is for the south of Scotland to be recognised as the European leader in mountain biking and this is an important step forward.

“There is still a lot of work to do to realise this vision and we will continue to work with the project partners and the local community to deliver the best project for the region.”

Councillor Mark Rowley added: “This project is a fantastic example of how projects funded by the Borderlands Inclusive Growth Deal can deliver multiple benefits, in this case attracting new businesses and jobs to the area and also attracting tourists from across the UK, Europe and beyond, building on the already well-established reputation of the Tweed Valley as one of the world’s top mountain biking destinations.”

Professor Nick Antonopoulos, Vice Principal for Research and Innovation at Edinburgh Napier University, said: “Today marks another important milestone for Edinburgh Napier and its partners in our journey towards making the South of Scotland the mountain bike capital of Europe.

“The Borderlands Growth Deal will build on the fantastic groundwork of the Mountain Bike Centre of Scotland, hosted by Edinburgh Napier University who have been supporting cycling innovation since 2012.

“This investment will take the work of Mountain Bike Centre of Scotland to the next level, helping to drive innovation and support product research and development, whilst working with local and international companies.

“Together, these projects will power commercial activity, attract inward investment and deliver positive outcomes in terms of public health and supporting carbon neutral products and processes.

“We are also hugely excited by the potential research opportunities for Edinburgh Napier colleagues across a range of academic disciplines, including exercise science, health and wellbeing, engineering, inclusion, product design, artificial intelligence, big data and tourism.”

South of Scotland Enterprise Chair, Russel Griggs OBE, added: “This is a transformational project which could really put the South of Scotland on the map as a global leader in the mountain biking industry.

“The potential wider economic and community benefits for the local area are significant in terms of inward investment and jobs, as well as bringing further UK and international tourism to the region.

“I am delighted the South of Scotland Enterprise will be working with various partners to realise this ambition.”

Johnson: Let’s get the jab done!

PM’s statement at coronavirus press conference: 18th March 2021

Our roadmap to freedom depends on the continued success of our vaccination programme, and so it is reasonable for people to want to be continually reassured not only that our vaccines are safe and effective but also that we have the supply that we need.

So I want to address both points today especially in the light of concerns you may have heard in some other countries about the Oxford AstraZeneca vaccine.

First, the independent Medicines and Healthcare products Regulatory Agency has reviewed the evidence, as it does every week.

They have confirmed that the benefits of the vaccine in preventing COVID far outweigh any risks and people should continue to get their vaccine when asked to do so and June will say a little bit more about that in a moment.

It’s also very important for our European friends that today the European Medicines Agency has come to a clear scientific conclusion and I quote – “this is a safe and effective vaccine.”

We also saw yesterday the evidence from Public Health England that a single dose of either vaccine provides 60 per cent protection against getting COVID.

and reduces the chances of hospitalisation by 80 per cent and the risk of death by 85 per cent.

So the Oxford jab is safe; and the Pfizer jab is safe – the thing that isn’t safe is catching Covid – which is why it’s so important that we all get our jabs as soon as our turn comes.

And as it happens, I’m getting mine tomorrow. And the centre where I’m getting jabbed is currently using the Oxford AstraZeneca vaccine for those receiving their first dose, and that is the one I’ll be having.

And let me also assure you – if you come forwards after receiving your letter, we have the jabs for you.

We’ve always said that in a vaccination programme of this pace and this scale, some interruptions in supply are inevitable and it is true that in the short term we are receiving fewer vaccines than we had planned for a week ago.

That is because of a delay in a shipment from the Serum Institute who are doing a herculean job in producing vaccines in such large quantities – and because of a batch that we currently have in the UK that needs to be retested – as part of our rigorous safety programmes.

So as a result we will receive slightly fewer vaccines in April than in March.

But that is still more than we received in February and the supply we do have will still enable us to hit the targets we have set.

That means that by 15 April we will be able to offer a first dose to all of you who are over 50, as well as those under 50 who are clinically vulnerable.

We will have the second doses that people need within the 12 week window – which means around 12 million people in April.

And we will still offer a first dose to every adult by the end of July.

So there is no change to the next steps of the roadmap.

We’ve now vaccinated over 25 million across our entire United Kingdom – more than the entire population of many countries

and our progress along the road to freedom continues unchecked.

We remain on track to reclaim the things we love, to see our families and friends again, to return to our local pubs, our gyms and sports facilities, and of course our shops, all as long as the data continue to go in the right direction and we meet our four tests.

And the way to ensure this happens is to get that jab when your turn comes.

So let’s get the jab done!

Thank you very much.

Coronavirus vaccine fears: Keep using Astra Zeneca, urges WHO

The World Health Organization (WHO) has urged countries not to pause Covid vaccinations, as several EU countries halted their rollouts of the Oxford AstraZeneca jab.

It said there was no evidence of a link between the vaccine and blood clots.

Germany, France, Italy and Spain have now joined Denmark, Norway and Iceland in halting vaccinations as a precaution while data is examined.

WHO’s vaccine safety experts meet today to discuss the Oxford AstraZeneca vaccine.

The European Medicines Agency (EMA) will also meet and is due to draw conclusions on Thursday. It has also said the vaccine should continue to be used.

Scotland’s First Minister Nicola Sturgeon sought to reassure anxious Scots over safety concerns yesterday.

She told the daily media briefing: “We are of course – as I’m sure you are too – aware that some countries, most recently the Netherlands and the Republic of Ireland, have paused their use of the AstraZeneca vaccine.

“You might be hearing reports of this in the media and you might have concerns as a result. So I wanted to take the opportunity today to address this directly.

“In the UK, the decision to suspend the use of any vaccine is a matter for the Medicines and Healthcare Products Regulatory Agency (MHRA).

“The MHRA has confirmed to us that there is no current evidence of an increase in blood clots being caused by the AstraZeneca vaccine. That is the issue that has caused the pause in some other countries.

“As you would expect, though, the MHRA is continuing to monitor this carefully, and it remains in regular contact with other regulators.

“There is, however, significant and growing evidence of the benefits of vaccination in reducing death, illness and we hope now, reducing transmission as well – and the vaccination programme continues to make very good progress.

“So for all these reasons and based on the advice and opinion of the MHRA, we continue to urge people to come forward for vaccination included with the AstraZeneca vaccine when you are invited to do so.“

Indeed, I can confirm that, as of 8.30 this morning, 1,908,991 people in Scotland have received the first dose of the vaccine.

“That is an increase of 20,294 since yesterday.

“In addition, 1,907 people yesterday received the second dose, which brings the total number of second doses now to 161,945.

“So as of now, virtually all people over the age of 65 have had the first dose of the vaccine. So too have 53% of 60-64 year olds; 41% of 55 to 59 year olds; and 33% of 50 to 54 year olds.

“As the Health Secretary indicated when she was here on Friday, we expect the pace of vaccination to pick up significantly again this week in line with increased supplies.

“So we are expecting that, taking first and second doses together, there will be around 400,000 vaccinations done over the course of this week.”

MHRA response to the precautionary suspensions of COVID-19 Vaccine AstraZeneca

‘It has not been confirmed that the reports of blood clots were caused by the AstraZeneca COVID-19 vaccine. People should still go and get their COVID-19 vaccine when asked to do so.’

Dr Phil Bryan, MHRA Vaccines Safety Lead said: “We are closely reviewing reports but the evidence available does not suggest the vaccine is the cause.

“Blood clots can occur naturally and are not uncommon. More than 11 million doses of the COVID-19 Vaccine AstraZeneca have now been administered across the UK, and the number of blood clots reported after having the vaccine is not greater than the number that would have occurred naturally in the vaccinated population.

“We are working closely with international counterparts in understanding the global safety experience of COVID-19 vaccines and on the rapid sharing of safety data and reports.

“People should still go and get their COVID-19 vaccine when asked to do so.”

Health charities back vaccines drive for those at risk

Charities write open letter to encourage those with underlying health conditions to come forward for the jab

More than half of cohort 6 have already been vaccinated

Vaccine drive includes NHS text alert sent to more than 2 million people in this group

People with underlying conditions including cancer, diabetes and heart disease are being encouraged to come forward for a Covid-19 vaccine by leading UK health charities.

Frontline charities, including Mencap, Diabetes UK and Lupus UK, have asked those with underlying medical conditions, their carers, and those with learning disabilities on their GP register, to book a vaccination to protect themselves and those around them from coronavirus.

People in cohort 6 have been prioritised for the vaccine because they have conditions that mean they are more likely to become seriously unwell from coronavirus.

More than half of those in cohort 6 have already received their first dose of the vaccine and it’s hoped that the charities’ letter – alongside text messages from the NHS – will help to increase take up further among those in this at-risk group.

The charities who signed the open letter are among 22 who have joined together in partnership to reassure those they support about the safety and effectiveness of the vaccine.

GP services already have been contacting this cohort but those who have not yet received a letter can get a quick and convenient appointment at a vaccination centre or community pharmacy by using the national booking system or calling 119. The NHS have sent text messages to people in this group with a link so they can book their appointment.

The vaccine is safe and effective and very few people are advised not to have it. However, if you have any concerns, you can discuss these if you book over the phone, or with a health professional at your appointment.

Health and Social Care Secretary Matt Hancock said: “The backing of the charities who work every day to support those who are entitled to a jab as part of cohort 6 is a great boost for the vaccine rollout and shows what we can achieve when we pull together.

“This open letter is a hugely important way to reassure those with underlying health conditions, and their carers, about the safety and effectiveness of the vaccine.

“The charities’ support for this national vaccine effort is invaluable in encouraging more people to come forward and helping us to save lives.”

These vital charities support those included in priority vaccination categories, including cohort 6 which covers individuals aged 16 to 64 with certain long-term conditions identified by the Joint Committee on Vaccination and Immunisation as being at higher clinical risk from Covid-19.

Underlying health conditions faced by people in cohort 6 include chronic respiratory, heart, kidney, liver disease and neurological conditions, including multiple sclerosis (MS) and epilepsy, stroke, vascular disease, diabetes mellitus, immunosuppression due to a health condition or treatment, asplenia or dysfunction of the spleen, morbid obesity, severe mental illness, as well as sickle cell, lupus and those on GP learning disability registers.

Cohort 6 also includes carers who are eligible for a carer’s allowance, or those who are the sole or primary carer of an elderly or disabled person who is at increased risk of Covid-19 mortality and therefore clinically vulnerable.

Minister for Vaccines Nadhim Zahawi said: “We have already given a first dose of the vaccine to more than half of those in cohort 6 and I am grateful to the charities who are encouraging more people in that group to come forward.

“The vaccine is our way out of this pandemic and offers the chance to protect yourself and others – that’s why it’s vital that people get their jab.

“This open letter should help to reassure those with any concerns the vaccine is safe and supported by more than twenty of our most trusted charities.

“I would like to thank them all for backing this life-saving campaign and offering their expertise and assistance to support the largest medical deployment in British history.”

Open letter

We are writing today to encourage people living with an underlying health condition in cohort 6 to come forward for a Covid-19 vaccine.

People with these conditions, including their carers, and those with learning disabilities on the learning disability register, have been prioritised by the Joint Committee on Vaccination and Immunisation because they are more likely to become seriously unwell from Covid-19.

The vast majority of you should already have been invited for vaccination and more than half of you have already received your first dose.

Some of you may still be waiting for a letter from your GP.

But the good news is, even if you have not received your letter yet, you can now get an appointment at a vaccination centre or community pharmacy, quickly and easily, by using the national booking system or calling 119 in England.

We are proud to support the vaccination roll-out and are here to support you.

The vaccine is safe and effective and very few people are advised not to have it. However, if you have any concerns, you can discuss these when you book, or with a health professional at your appointment.

Over 20 million people in the UK have had their first dose and great progress has been made by the NHS.

We are very pleased to see the Covid-19 vaccination roll-out providing protection for people, like you, who are most at risk from the virus.

Underlying health conditions in cohort 6 include chronic respiratory, heart, kidney, liver disease and neurological conditions, including multiple sclerosis (MS) and epilepsy, stroke, vascular disease, diabetes mellitus, immunosuppression, due to a health condition or treatment, asplenia or dysfunction of the spleen, morbid obesity, severe mental illness, as well as sickle cell, lupus and those on GP learning disability registers.

The vaccines that have been approved for use in the UK have met the strict safety standards set by the medicines regulator on safety, quality and effectiveness.

To protect yourself and your family, friends and colleagues, you still need to follow the current government guidance on social contact after receiving your vaccine.

Please come forward to have the jab. It will help save lives and offers the best form of protection from this terrible virus.

The organisations within the partnership, 18 of which have also signed the letter, are:

ACLT (African Caribbean Leukaemia Trust)
Anthony Nolan
Asthma UK
British Heart Foundation
British Liver Trust
British Lung Foundation
Cancer Research UK
Carers UK
Diabetes UK
Epilepsy Action
Kidney Care UK
Kidney Research UK
Lupus UK
Macmillan Cancer Support
Mencap
MS Society
National Kidney Federation
Rethink Mental Illness
Sickle Cell Society
Stroke Association
Terrence Higgins Trust
Versus Arthritis

Unpaid carers are included in cohort 6 providing they:

are eligible for a carer’s allowance
are identified as a primary carer by their GP
are receiving support following a carer’s assessment by their local council or from a local carer’s organisation
are the sole or primary carer who provides close personal care or face to face support for an elderly or disabled person who is clinically vulnerable to COVID-19

UK Government must act now as report shows infection control guidelines ‘fundamentally flawed’

A report commissioned by the Royal College of Nursing shows that the government’s COVID-19 infection control guidelines, which are used across the UK, are “flawed and need replacing”.

The report, written by independent experts, analysed a literature review which underpins the current guidance and found that the review met just four of the 18 criteria the experts deemed essential. Crucially, the report found that the review failed to consider a key way in which COVID-19 is transmitted – airborne infection – about which growing evidence has emerged during the pandemic.

For these reasons, the experts concluded the review provided only a “superficial account” of the available COVID-19 evidence and that the current guidelines based on the review need replacing.

In the report, the authors Professor Dinah Gould, an Honorary Professor of Nursing at London’s City University, and Dr Edward Purssell, also from City University, said: “UK infection prevention and control (IPC) guidance to prevent the spread of COVID-19 in health care settings, and the rapid reviews of the literature on which it was based, still identify droplet spread and hands as the major route, based on early advice from the World Health Organization (WHO).
“Updated evidence indicates that aerosol spread is much more significant and the original advice from the WHO has been superseded. The UK guidelines are still based on this outdated evidence, however. They urgently need thorough revision and replacing.”

The report highlights that the guidelines omit detail on the importance of ventilation and advise that higher level personal protective equipment (PPE) must only be provided in certain high-risk settings like intensive care, but that it’s up to individual health trusts to decide whether or not to provide them more widely to other staff.

This has caused huge concern for members, especially with the emergence of highly infectious new COVID-19 variants. Members have also expressed concern about the lack of action on ventilation in UK hospitals as research suggests airborne transmission is a particular problem in poorly ventilated rooms.

The RCN has repeatedly tried to engage the government on these issues and is calling for all NHS staff to be given a higher level of PPE as a precautionary measure pending the outcome of a review.

RCN Chief Executive & General Secretary Dame Donna Kinnair said: “We have been battling this pandemic for more than a year now. ‘Following the science’ is a hollow boast when we have evidence showing the flaws.

“The report and its findings must launch an official review and not be swept under the carpet as an inconvenience.

“Health care workers need to know everything possible is being done to keep them protected. It is inadequate to say they have masks if they aren’t fit for purpose. Staff are scared for themselves and their families and left any longer it’ll turn to anger.”